Published in Ann Surg on July 01, 2000
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine (Baltimore) (2015) 1.88
Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg (2004) 1.79
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg (2005) 1.41
Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg (2004) 1.28
Surgical treatment of hepatocellular carcinoma. HPB (Oxford) (2005) 1.04
HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03
Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma. World J Gastroenterol (2002) 1.03
The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. World J Surg Oncol (2013) 0.99
The liver hanging manoeuvre. HPB (Oxford) (2009) 0.95
Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg (2005) 0.93
Surgery for large primary liver cancer more than 10 cm in diameter. J Cancer Res Clin Oncol (2003) 0.90
Bimanual 'bi-finger' liver hanging maneuver: an alternative and safe technique for liver hanging. HPB (Oxford) (2007) 0.86
Anterior vs conventional approach hepatectomy for large liver cancer: a meta-analysis. World J Gastroenterol (2014) 0.85
Right hepatectomy using Glissonean pedicle transection method with anterior approach (with video). J Hepatobiliary Pancreat Sci (2012) 0.84
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford) (2015) 0.84
The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg (2014) 0.80
Outcomes of resection of giant hepatocellular carcinoma in a tertiary institution: does size matter? HPB (Oxford) (2015) 0.80
A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case. Surg Today (2013) 0.80
The hanging manoeuver to complete liver resection for a locally advanced angiosarcoma: A case report. Int J Surg Case Rep (2015) 0.79
Liver hanging maneuver for right hemiliver in situ donation--anatomical considerations. HPB (Oxford) (2006) 0.76
Peri-operative filtration of disseminated cytokeratin positive cells in patients with colorectal liver metastasis. Langenbecks Arch Surg (2004) 0.76
Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival. World J Gastroenterol (2017) 0.75
Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. Int J Mol Sci (2017) 0.75
Total vascular exclusion technique for resection of hepatocellular carcinoma. World J Gastroenterol (2003) 0.75
Anterior approach combined with infrahepatic inferior vena cava clamping right hepatic resection for large hepatocellular carcinoma: A prospective randomized controlled trial. Medicine (Baltimore) (2016) 0.75
Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol (2015) 0.75
The Preference for Anterior Approach Major Hepatectomy: Experience Over 3 Decades and a Propensity Score-Matching Analysis in Right Hepatectomy for Hepatocellular Carcinoma. Medicine (Baltimore) (2015) 0.75
Complex liver resections for colorectal metastases: are they safe in the low-volume, resource-poor Caribbean setting? Case Rep Surg (2015) 0.75
Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol (2017) 0.75
A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma. HPB (Oxford) (2016) 0.75
Modified hanging manoeuvre facilitates inferior vena cava resection and reconstruction during extended right hepatectomy: A technical case report. Mol Clin Oncol (2017) 0.75
Superior approach for the exclusion of hepatic veins in major liver resection: a safe and easy technique. Surg Today (2009) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg (1993) 2.06
Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg (1995) 1.99
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 1.92
No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery (1999) 1.91
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res (1998) 1.68
Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology (1993) 1.62
Results of 280 liver resections for hepatocellular carcinoma. Arch Surg (1996) 1.45
Hepatic function and liver resection. J Gastroenterol Hepatol (1991) 1.44
Hepatic resection for hepatocellular carcinoma -- Japanese experience. Hepatogastroenterology (1998) 1.39
Extrahepatic division of the right hepatic vein in hepatectomy. Hepatogastroenterology (1991) 1.38
The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer (1993) 1.29
Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology (1999) 1.28
Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25
Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol (1996) 1.21
Operative risks of major hepatic resections. Hepatogastroenterology (1998) 1.18
Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres. Surgery (1989) 1.05
Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer (1983) 1.04
Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer. Am J Surg (1999) 1.01
Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res (1996) 0.99
Morbidity and mortality after major hepatic resection in cirrhotic patients with hepatocellular carcinoma. HPB Surg (1988) 0.98
Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases. Hepatogastroenterology (1992) 0.93
Hepatic resection for hepatocellular carcinoma. World J Surg (1993) 0.91
Peri-operative mortality in hepatic resection. Aust N Z J Surg (1991) 0.89
Right hepatic lobectomy. Am J Surg (1984) 0.85
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol (2001) 2.99
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55
Compliance with postoperative instructions: a telephone survey of 750 day surgery patients. Anaesthesia (2001) 2.53
Mismatch repair co-opted by hypermutation. Science (1998) 2.49
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol (2000) 2.36
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene (2007) 2.19
Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09
Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther (2014) 2.06
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California. J Clin Microbiol (1993) 2.03
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med (1979) 2.01
A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg (1982) 2.00
Two cases of acrometastasis to the hands and review of the literature. Curr Oncol (2008) 2.00
The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry (1993) 1.99
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg (1996) 1.97
Analysis of reduced death and complication rates after esophageal resection. Ann Surg (2001) 1.96
Adaptive radiation therapy. Phys Med Biol (1997) 1.94
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft. Ann Surg (2000) 1.86
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg (2000) 1.82
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg (1997) 1.78
Time-Resolved X-ray Diffraction Study of Solid Combustion Reactions. Science (1990) 1.76
Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol (2012) 1.74
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73